The cost-of-living crisis is having a huge impact on fertility patients, making the sector ripe for disruption. A fertility expert tells HBI cunning new entrants will be the winners while established PE could well be the losers.
A new year brings a new wave of senior appointments. After four years of service at international teleradiology specialist Medica, CEO Stuart Quin is leaving to join London-based healthcare investment advisor GHO Capital as a new partner. Former Voyage Care CEO Andrew Cannon is lined up as Quin’s replacement, while mydentist executive chairman Tom Riall is Medica’s new chair.
After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.
Watch this exclusive interview with Richard Banks, chief strategy officer and European managing director of global fertility company Virtus Health, as he shares valuable insights into the evolving market landscape.
Ireland has seen significant wage inflation as its economy has grown over the past decade, which is attracting talent from overseas. But local imaging operators tell us this isn’t happening quickly enough to fill workforce gaps. There are significant shortages of radiologists and radiographers, as well as most other categories of health care workers.
The longstanding bidding war for pan-European diagnostic firm Alliance Medical Group is over, with iCON Infrastructure confirmed as the new buyer. The £910m deal ends months of speculation. HBI asks a UK-based consultant what this means for the market.
HBI hears that the longstanding sale of UK diagnostic firm Alliance Medical Group is imminent, with two bidders left in the process and pan-European operator Affidea tipped to be the front-runner. We speak to three market experts to find out more about the deal which is being valued at around $800m-$1bn.
For years there has been a trend towards using outpatient services wherever possible - to improve patient outcomes, to better use an increasingly scarce workforce, and to increase cost efficiency. On the “Outpatient differential” panel at HBI 2023, how this push looks across the world was a key topic for discussion.